Association of IL-2RA/CD25 with type 1 diabetes in the Belgian population

Human Immunology

Volumn 71, Issue 12, 2010, Pages 1233-1237

  Aminkeng, Folefac ^a   Weets, Ilse ^a   Van Autreve, Jan E ^a   Koeleman, Bobby P C ^b   Quartier, Erik ^a   Van Schravendijk, Chris ^a   Gorus, Frans K ^a   Van der Auwera, Bart J R ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autoimmune disease; CD25; Correlation; Genetic association; IL 2Ra; Interleukin 2 receptor ; Type 1 diabetes

Indexed keywords

GENOMIC DNA; HLA DQ ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADOLESCENT; ADULT; AGE; ARTICLE; BELGIUM; CHILD; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; AUTOANTIBODIES; BELGIUM; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; YOUNG ADULT;

EID: 78149411413     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.09.006     Document Type: Article

References (20)

1. Xavier R.J., Rioux J.D. Genome-wide association studies: A new window into immune-mediated diseases. Nat Rev Immunol 2008, 8:631-643.
2. Wang X., Rickert M., Garcia K.C. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science 2005, 310:1159-1163.
3. Shevach E.M. Certified professionals;CD4(+)CD25(+) suppressor T cells. J Exp Med 2001, 193:F41-F46.
4. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., Tree T.I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005, 54:92-99.
5. Viglietta V., Baecher-Allan C., Weiner H.L., Hafler D.A. Loss of functional suppression by CD4+CD25 + regulatory T cells in patients with multiple sclerosis. J Exp Med 2004, 199:971-979.
6. Lowe C.E., Cooper J.D., Brusko T., Walker N.M., Smyth D.J., Bailey R., et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 2007, 39:1074-1082.
7. Maier L.M., Lowe C.E., Cooper J., Downes K., Anderson D.E., Severson C., et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet 2009, 5;:e1000322.
8. Qu H.Q., Bradfield J.P., Belisle A., Grant S.F., Hakonarson H., Polychronakos C. The type I diabetes association of the IL2RA locus. Genes Immun 2009, 10(Suppl 1):S42-S48.
9. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl 1):S62-S67. American Diabetes Association (ADA).
10. Weets I., Van Autreve J., Van der Auwera B., Schuit F., Du Caju M., Decochez K., et al. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: Possible relation to increased body mass index. Diabetologia 2001, 44:40-47.
11. Cole T.J., Freeman J.V., Preece M.A. Body mass index reference curves for the UK. Arch Dis Child 1990, 73:25-29.
12. Van der Auwera B.J., Schuit F.C., Weets I., Ivens A., Van Autreve J.E., Gorus F.K. Relative and absolute HLA-DQA1-DQB1-linked risk for developing type 1 diabetes before 40 years of age in the Belgian population: Implications for future prevention studies. Hum Immunol 2002, 63:40-50. Belgian Diabetes Registry.
13. Decochez K., Tits J., Coolens J.L., Van Gaal L., Krzentowski G., Winnock F., et al. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. Diabetes Care 2000, 23:838-844.
14. Koeleman B.P., Dudbridge F., Cordell H.J., Todd J.A. Adaptation of the extended transmission/disequilibrium test to distinguish disease associations of multiple loci: The conditional extended transmission/disequilibrium test. Ann Hum Genet 2000, 64:207-213.
15. Dupont W.D., Plummer W.D. Power and sample size calculations. A review and computer program. Control Clin Trials 1990, 11:116-128.
16. Leslie R.D., Delli Castelli M. Age-dependent influences on the origins of autoimmune diabetes: Evidence and implications. Diabetes 2004, 53:3033-3040.
17. Gorus F.K. Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Diabetes/Metab Rev 1997, 13:247-274. Belgian Diabetes Registry.
18. Vella A., Cooper J.D., Lowe C.E., Walker N., Nutland S., Widmer B., et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 2005, 76:773-779.
19. Qu H.Q., Montpetit A., Ge B., Hudson T.J., Polychronakos C. Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 2007, 56:1174-1176.
20. Klinker M.W., Schiller J.J., Magnuson V.L., Wang T., Basken J., Veth K., et al. Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subjects. Immunogenetics 2009, 62:101-107.